Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry. [electronic resource]
Producer: 20191101Description: 314-322 p. digitalISSN:- 1879-1484
- Adult
- Anticholesteremic Agents -- therapeutic use
- Biomarkers -- blood
- Cardiovascular Diseases -- epidemiology
- Cholesterol, LDL -- blood
- Down-Regulation
- Drug Therapy, Combination
- Female
- Genetic Predisposition to Disease
- Germany -- epidemiology
- Heredity
- Humans
- Hyperlipoproteinemia Type II -- blood
- Male
- Middle Aged
- PCSK9 Inhibitors
- Pedigree
- Phenotype
- Proprotein Convertase 9 -- metabolism
- Risk Assessment
- Risk Factors
- Serine Endopeptidases -- therapeutic use
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.